ArticleApplied biochemistry and biotechnology2023

Anti-Fungal Potential of Structurally Diverse FDA-Approved Therapeutics Targeting Secreted Aspartyl Proteinase (SAP) of Candida albicans: an In Silico Drug Repurposing Approach.

Sivaraman Dhanasekaran et al.PubMed ↗Publisher ↗

No numbers read from the abstract.